Related Experiment Videos
Coronary artery spasm: clinical experience and implications
Hospital Practice (Office Ed.)
|April 1, 1983
Insights
Coronary vasospasm often involves underlying atherosclerosis, even if not visible on angiography. All patients with coronary vasospasm need treatment, and calcium channel blockers may improve the disease
Area of Science:
- Cardiology
- Vascular Biology
- Pharmacology
Background:
- Coronary vasospasm can occur in arteries that appear normal on angiography.
- Histological examination frequently reveals atherosclerotic lesions in these cases.
- The presence of atherosclerosis is a key consideration in managing coronary vasospasm.
Purpose of the Study:
- To emphasize the necessity of treatment for all coronary vasospasm patients.
- To highlight the potential disease-modifying effects of calcium channel blockers.
- To discuss the relationship between coronary vasospasm and atherosclerosis.
Main Methods:
- Review of histological findings in patients with coronary vasospasm.
- Analysis of clinical outcomes in patients treated for coronary vasospasm.
- Evaluation of the role of calcium channel blockers in managing coronary vasospasm.
Main Results:
- Histological evidence of atherosclerosis is consistently found in coronary vasospasm.
- Angiographic appearance does not exclude underlying atherosclerotic disease.
- Calcium channel blockers offer both symptomatic relief and potential disease modification.
Conclusions:
- Therapy is mandatory for all patients diagnosed with coronary vasospasm.
- Calcium channel blockers are a cornerstone treatment, potentially altering disease progression.
- Understanding the link between vasospasm and atherosclerosis is crucial for effective patient management.
Abstract:
Although coronary vasospasm may occur in vessels that arteriographically appear fully patent, histologically there is virtually always some evidence of atherosclerotic lesions. Whether or not atherosclerosis can be angiographically documented, all patients with coronary vasospasm require therapy. Calcium channel blockers may actually alter the course of the disease process as well as relieve symptoms.